KRAS WT Peptide (TFA)
KRAS WT Peptide TFA is the trifluoroacetate salt of KRAS WT Peptide (HY-P11355) . KRAS WT Peptide is the normal sequence peptide of the Kirsten rat sarcoma virus (KRAS) gene without oncogenic mutations. KRAS WT Peptide can be used for the study of evaluating the specificity and safety of KRAS-targeted immunotherapies[1].
Product Specifications
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Cancer
Purity
98.61
Smiles
O=C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C)C(NCC(NCC(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C(C)C)N.OC(C(F)(F)F)=O.[x]
Molecular Formula
C37H67N11O11.xC2HF3O2
Molecular Weight
841.99 (free base)
References & Citations
[1]Zheng W, et al. Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development. Oncol Res. 2024 Nov 13;32 (12) :1837-1850.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1377662-01 0.02 mg (E-Coli)
Recombinant Mesorhizobium sp. Glutamate 5-kinase (proB)
Ask
View Details